Table 4. Analyses Stratified By Adherence Measure, Study Location, Design and Power.
k | OR | (95% CI) | p | I2 | Heterogeneity test | |
Necessity | ||||||
UK study | 32 | 2.201 | 1.786–2.713 | <0.001 | 72.72%*** | Q(1) = 7.67, p<0.05 |
Non-UK study | 64 | 1.573 | 1.405–1.761 | <0.001 | 74.79%*** | |
Concerns | ||||||
UK study | 31 | 0.403 | 0.335–0.485 | <0.001 | 62.75%*** | Q(1) = 7.61, p<0.05 |
Non-UK study | 62 | 0.555 | 0.486–0.635 | <0.001 | 82.48%*** | |
Necessity | ||||||
Subjective adherence measure | 83 | 1.737 | 1.565–1.929 | <0.001 | 75.54%*** | Q(1) = 0.031, p = 0.86 |
Objective adherence measure | 13 | 1.817 | 1.114–2.963 | 0.017 | 86.20%*** | |
Concerns | ||||||
Subjective adherence measure | 81 | 0.485 | 0.429–0.549 | <0.001 | 82.84%*** | Q(1) = 13.55, p<0.001 |
Objective adherence measure | 12 | 0.726 | 0.609–0.866 | <0.001 | 8.93% | |
Necessity | ||||||
Prospective/longitudinal | 18 | 1.526 | 1.243–1.874 | <0.001 | 63.02*** | Q(1) = 1.82, p = 0.18 |
Cross-sectional | 78 | 1.798 | 1.595–2.027 | <0.001 | 79.49%*** | |
Concerns | ||||||
Prospective/longitudinal | 18 | 0.449 | 0.356–0.567 | <0.001 | 70.88%*** | Q(1) = 1.14, p = 0.29 |
Cross-sectional | 75 | 0.519 | 0.458–0.588 | <0.001 | 81.28%*** | |
Necessity | ||||||
Low power | 18 | 1.848 | 1.290–2.646 | 0.001 | 46.19%* | Q(1) = 0.12, p = 0.73 |
High power | 78 | 1.730 | 1.550–1.930 | <0.001 | 80.16*** | |
Concerns | ||||||
Low power | 17 | 0.488 | 0.371–0.643 | <0.001 | 0.00% | Q(1) = 0.05, p = 0.82 |
High power | 76 | 0.505 | 0.448–0.570 | <0.001 | 83.83%*** |
Note. *p<.05, ***p<.001 for Q statistic.